3.2. Spatial Heterogeneity of Diffuse Astrocytomas Was Associated with Dysregulation of Specific Molecular Pathways and HMGB2 Was Identified as a Putative Driver of Tumor Progression. The gene discussed is HMGB2; the disease is neoplasm.